Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles, marking one of the largest AI partnerships in the pharma industry to date. According to ...

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million to ...

The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...

BioMarin’s Voxzogo (vosoritide) won FDA approval in paediatric achondroplasia in November 2021 and secured a label extension in October 2023, but this therapy is a daily injection, while Yuviwel is a ...

New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with Asia.

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Stephen Ranjan believes teamwork is just as crucial as technology in building successful digital healthcare solutions in the pharma space Stephen Ranjan learned how to be innovative while growing up ...

ACTO’s CxZone won the Innovation award in the AI Roleplay category for its targeted use of AI roleplay to address persistent challenges in pharmaceutical field engagement. One of the most significant ...

When Pfizer PFE (NYSE: PFE) acquired Biohaven Pharmaceutical Holding Company Ltd., the maker of a portfolio of calcitonin gene-related peptide (CGRP) receptor antagonists such as Nurtec ODT ...

While the FDA maintains the legal right to make prescription meds OTC, legal expert Heidi Gertner believes that this wider shift depends on pharma’s engagement.

Márcio Temtem, Hovione, discusses how to tackle pharma complexity via regional growth in the US, Ireland, and Portugal, using digital tools to accelerate development. Márcio Temtem, vice president, ...